Report from the Evaluation Indicators Working Group: Guidelines for Monitoring Breast Screening Program Performance

[Previous] [Table of Contents] [Next]

References

1. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-54.
2. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-209.
3. Europe Against Cancer. European guidelines for quality assurance in mammographic screening. Luxembourg: Office for Official Publications of the European Commission, June 1996.
4. Europe Against Cancer. European guidelines for quality assurance in mammographic screening. Luxembourg: Office for Official Publications of the European Commission, January 2001.
5. Standards for the NHS Breast Screening Programme (updated August 1998). Sheffield, England: NHSBSP publication.
6. Informing choice in breast screening: Breast Cancer Screening Program annual review 2001. Sheffield, England: NHSBSP publication, 2001.
7. Commonwealth Department of Human Services and Health. National program for the early detection of breast cancer: national accreditation requirements. Canberra, Australia: Commonwealth Department of Human Services and Health, March 1994.
8. Health Canada. Organized breast screening programs in Canada 1997 and 1998 report. Ottawa: Minister of Public Works and Government Services Canada, 2001.
9. Gaudette LA, Altmayer CA, Nobrega KMP, Lee J. Trends in mammography utilization, 1981 to 1994. Health Reports 1996;8(3).
10. Cancer incidence in five continents (volume VII). Lyon: IARC Scientific Publication No. 143, 1997.
11. The Workshop Group. Reducing deaths from breast cancer in Canada. Can Med Assoc J 1989;141;199-201.
12. Health Canada. National workshop on organized breast cancer screening programs: Report of the theme discussion group. Ottawa: Health Canada, 1997.
13. Horne T, Evaluation Indicators Working Group. Proposed indicators for performance and quality of breast screening programs in Canada. Ottawa: Health Canada, April 2000.
14. Maxwell CJ, Bancej CM, Snider J. Predictors of mammography use among Canadian women aged 50-69: findings from the 1996/97 National Population Health Survey. Can Med Assoc J 2001;164(3):329-34.
15. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization, 1968.
16. Day NE, Williams DRR, Khaw KT. Breast cancer screening programs: the development of a monitoring and evaluation system. Br J Cancer 1989;59:954-58.
17. Tabar I, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age: new results from the Swedish two-county trial. Cancer 1995;75:2507-17.
18. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S et al. Breast cancer screening with mammography: overview of the Swedish randomized trials. Lancet 1993;341:973-8.
19. Duffy SW, Hill C, Estève J. Quantitative methods for the evaluation of cancer screening. London: Arnold, 2001.
20. Evans AJ, Pinder SE, Ellis IO, Wilson ARM. Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? J Med Screen 2001;8:149-51.
21. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 1. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. Can Med Assoc J 1998;158(suppl):3S-8S.
22. Olivotto IA, Bancej C, Goel V, Snider J, McAuley RG, Irvine B, Kan L, Mirsky D, Sabine MJ, McGilly R, Caines JS. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. Can Med Assoc J 2001;165(3):303-4.
23. Blanks RG, Moss SM, Wallis MG. Monitoring and evaluating the UK National Health Service Breast Screening Programme: evaluating the variation in radiological performance between individual programmes using PPV-referral diagrams. J Med Screen 2001;8:24-8.
24. Draft Breastscreen Australia Monitoring Plan, National Advisory Committee, work in progress.
25. Moss SM, Blanks RG. Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. J Epidemiol Community Health 1998;52:111-15.
26. Rickard MT, Taylor RJ, Fazli MA, El Hassan N. Interval breast cancers in an Australian mammographic screening program. Med J Aust 1998;169:184-87.
27. W.H.O. Public Health Papers No. 34. Geneva: World Health Organization, 1968.

[Previous] [Table of Contents] [Next]